Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.09 USD | +3.58% |
|
-2.40% | +67.71% |
Jun. 02 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
Jun. 01 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +3.58% | -2.40% | +67.71% | +49.52% | - | 951M | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- CGEM Stock
- Charts Cullinan Therapeutics, Inc.
- Comparison Chart